Eli Lilly recently spoke out against proposed tariffs on pharmaceuticals, warning they could increase drug costs and restrict patient access. The drugmaker said it has invested more than $50 billion ...

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...

Eli Lilly is sharply increasing the UK price of its weight-loss and diabetes drug Mounjaro, with the cost of some doses set to rise by as much as 170 percent from September.

As the Trump administration works to implement a “most-favored nation” policy, Lilly said it’s “rebalancing” drug prices to ...

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

Late last month, President Donald Trump issued letters to Lilly CEO David Ricks and to the CEOs of roughly a dozen other ...

MOUNJARO prices in the UK could double when the fat jab’s manufacturer hikes pharmacy rates next month. It threatens to spark ...

Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White ...

Eli Lilly CEO David Ricks recently addressed emerging national security concerns surrounding the manufacturing of essential medications in the United States, coinciding with the Trump administration's ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

More than five years after the Covid-19 pandemic first ravaged the nation, many Americans are still dealing with the social ...

South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.